Patents by Inventor Geraldine Deliencourt-Godefroy
Geraldine Deliencourt-Godefroy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240124510Abstract: The present invention relates to compounds of the following formula (I): as well as their preparation process; their use in cosmetic or dermatological applications, in particular for the treatment and/or prevention of skin aging, skin protection or skin regeneration; for skin plumping and/or skin volumizing and/or skin densifying, and/or wrinkle filling and/or skin or hair moisturising and/or skin or hair relipiding and/or stimulation of hair growth; for the treatment of dry skin and/or atopic dermatitis and/or eczema and/or psoriasis; for the treatment and/or prevention of a fibrosis disease (e.g. an excessive scar such as a keloid or hypertrophic scar) or for healing; or for the treatment of inflammation (e.g. chronic, low-grade inflammation); and their use as adjuvant for preservation and/or protection and/or regeneration of a biological material or a microorganism.Type: ApplicationFiled: January 20, 2022Publication date: April 18, 2024Applicant: TFCHEMInventors: Géraldine Deliencourt Godefroy, Jocelyne Legoedec, Lénaïg Lopes
-
Publication number: 20220267380Abstract: The present invention relates to a glycopeptide of the following formula I: or a tautomer, a stereoisomer or a mixture of stereoisomers thereof in any proportions, in particular a mixture of enantiomers, and particularly a racemate mixture, and/or a physiologically acceptable salt and/or solvate thereof, in which:—n represents an integer from 1 to 6,—m represents 0 or 1,10—p represents 0 or 1—R represents H, F, CH3, CH2F, or CH2OH,—R1, R2 and R3 represent, independently from one another, H, F, or OH,—R4 represents a hydrogen, a halogen, or OH,—R6 and R7 represent, independently from each other, a hydrogen, a (C1-C6)alkyl, an aryl, or an aryl-(C1-C6)alkyl, and—R8 represents H or a CO-(C1-C20)alkyl, useful for skin plumping and/or skin volumizing and/or skin densifying and/or wrinkle filling and/or skin or hair moisturizing and/or skin or hair relipiding and/or stimulation of hair growth and/or for the treatment of dry skin and/or atopic dermatitis and/or atopic eczema and/or psoriasis, due to its ability to inType: ApplicationFiled: July 17, 2020Publication date: August 25, 2022Applicant: TFCHEMInventors: Géraldine Deliencourt-Godefroy, Jocelyne Legoedec
-
Patent number: 10744181Abstract: The present invention relates to a compound of the following formula (I), as well as to a pharmaceutical composition comprising at least one compound of following formula (I) and at least one pharmaceutically acceptable excipient, for use in the treatment and/or prevention and/or attenuation of fibrosis diseases, in particular excessive scars such as keloids or hypertrophic scars.Type: GrantFiled: January 30, 2017Date of Patent: August 18, 2020Assignee: TFCHEMInventors: Géraldine Deliencourt-Godefroy, Jocelyne Legoedec
-
Patent number: 10640441Abstract: The present invention relates to a compound having the following formula (I) as well as a method for preparing such a compound, a cosmetic or pharmaceutical composition containing such a compound, and the use thereof as a depigmenting, lightening, bleaching or whitening agent and for treating pigmentation disorders, notably by topical application on the skin.Type: GrantFiled: August 24, 2017Date of Patent: May 5, 2020Assignee: TFCHEMInventors: Geraldine Deliencourt-Godefroy, Lenaig Lopes
-
Publication number: 20190388501Abstract: The present invention relates to a compound of the following formula (I), as well as to a pharmaceutical composition comprising at least one compound of following formula (I) and at least one pharmaceutically acceptable excipient, for use in the treatment and/or prevention and/or attenuation of fibrosis diseases, in particular excessive scars such as keloids or hypertrophic scars.Type: ApplicationFiled: January 30, 2017Publication date: December 26, 2019Applicant: TFCHEMInventors: Géraldine Deliencourt-Godefroy, Jocelyne Legoedec
-
Publication number: 20190322608Abstract: The present invention relates to a compound having the following formula (I) as well as a method for preparing such a compound, a cosmetic or pharmaceutical composition containing such a compound, and the use thereof as a depigmenting, lightening, bleaching or whitening agent and for treating pigmentation disorders, notably by topical application on the skin.Type: ApplicationFiled: August 24, 2017Publication date: October 24, 2019Applicant: TFCHEMInventors: Geraldine DELIENCOURT-GODEFROY, Lenaig LOPES
-
Patent number: 10351501Abstract: The present invention relates to a compound having the formula (I), as well as a method for preparing such a compound, a cosmetic or pharmaceutic composition containing such a compound, and the use thereof as a depigmenting, lightening, bleaching or whitening agent and for treating pigmentation disorders, notably by topical application on the skin.Type: GrantFiled: March 4, 2016Date of Patent: July 16, 2019Assignee: TFCHEMInventors: Géraldine Deliencourt-Godefroy, Lénaïg Lopes
-
Patent number: 10100088Abstract: The present invention relates to a compound of the following formula (I): in which at least one and only one group chosen among R5, R6 and R7 is a group of the following formula: The present invention relates also to uses thereof for preservation and/or protection and/or regeneration of biological materials and or microorganisms and for cosmetic or dermatological applications such as anti-aging, skin protection and skin regeneration; to culture, storage and/or preservation media comprising such a compound; to cosmetic or dermatological compositions comprising such a compound; to processes for preparing such a compound; and to synthesis intermediates.Type: GrantFiled: March 17, 2015Date of Patent: October 16, 2018Assignee: TFCHEMInventors: Geraldine Deliencourt-Godefroy, Thibaut Martin
-
Publication number: 20180029967Abstract: The present invention relates to a compound having the formula (I), as well as a method for preparing such a compound, a cosmetic or pharmaceutic composition containing such a compound, and the use thereof as a depigmenting, lightening, bleaching or whitening agent and for treating pigmentation disorders, notably by topical application on the skin.Type: ApplicationFiled: March 4, 2016Publication date: February 1, 2018Applicant: TFCHEMInventors: Géraldine DELIENCOURT-GODEFROY, Lénaïg LOPES
-
Publication number: 20170015709Abstract: The present invention relates to a compound of the following formula (I): in which at least one and only one group chosen among R5, R6 and R7 is a group of the following formula: The present invention relates also to uses thereof for preservation and/or protection and/or regeneration of biological materials and or microorganisms and for cosmetic or dermato logical applications such as anti-aging, skin protection and skin regeneration; to culture, storage and/or preservation media comprising such a compound; to cosmetic or dermato logical compositions comprising such a compound; to processes for preparing such a compound; and to synthesis intermediates.Type: ApplicationFiled: March 17, 2015Publication date: January 19, 2017Applicant: TFCHEMInventors: Geraldine Deliencourt-Godefroy, Thibaut Martin
-
Patent number: 9434670Abstract: The present invention relates to a compound of the following formula (I): as well as its process of preparation, pharmaceutical and cosmetics composition comprising it and use thereof, notably as an inhibitor of the sodium-dependent glucose co-transporter, such as SGLT1, SGLT2 and SGLT3, in particular in the treatment or prevention of diabetes, and more particularly type-II diabetes, diabetes-related complications, such as arthritis of the lower extremities, cardiac infarction, renal insufficiency, neuropathy or blindness, hyperglycemia, hyperinsulinemia, obesity, hypertriglyceridemia, X syndrome and arteriosclerosis, as well as for its use as an anticancer, anti-infective, anti-viral, anti-thrombotic or anti-inflammatory drug, or for lightening, bleaching, depigmenting the skin, removing blemishes from the skin, particularly age spots and freckles, or preventing pigmentation of the skin.Type: GrantFiled: May 29, 2012Date of Patent: September 6, 2016Assignee: TFCHEMInventors: Geraldine Deliencourt-Godefroy, Lenaig Lopes
-
Patent number: 9175044Abstract: The present invention relates to compounds of formula (I): or a pharmaceutically acceptable salt thereof, a tautomer, a stereoisomer or a mixture of stereoisomers in any proportion, in particular a mixture of enantiomers, and particularly a racemate mixture, as well as to their process of preparation, their use in the peptide synthesis, said peptide and the use of said peptide.Type: GrantFiled: December 22, 2011Date of Patent: November 3, 2015Assignee: TFCHEMInventors: Geraldine Deliencourt-Godefroy, Hyacinthe Fillon, Thibaut Martin
-
Patent number: 9062313Abstract: The present invention concerns compounds of the following formula (I) or a pharmaceutically acceptable salt thereof, a stereoisomer or a mixture of stereoisomers in any proportion, in particular a mixture of enantiomers, and particularly a racemate mixture, in which R represents H, OH or OR19, as well as processes for preparing these compounds and their use as inducer for the transcription of genes under control of the lac promoter.Type: GrantFiled: August 8, 2012Date of Patent: June 23, 2015Assignee: TFCHEMInventors: Géraldine Deliencourt-Godefroy, Hyacinthe Fillon
-
Publication number: 20140199727Abstract: The present invention concerns compounds of the following formula (I) or a pharmaceutically acceptable salt thereof, a stereoisomer or a mixture of stereoisomers in any proportion, in particular a mixture of enantiomers, and particularly a racemate mixture, in which R represents H, OH or OR19, as well as processes for preparing these compounds and their use as inducer for the transcription of genes under control of the lac promoter.Type: ApplicationFiled: August 8, 2012Publication date: July 17, 2014Applicant: TFCHEMInventors: Geraldine Deliencourt-Godefroy, Hyacinthe Fillon
-
Publication number: 20140105839Abstract: The present invention relates to a compound of the following formula (I): as well as its process of preparation, pharmaceutical and cosmetics composition comprising it and use thereof, notably as an inhibitor of the sodium-dependent glucose co-transporter, such as SGLT1, SGLT2 and SGLT3, in particular in the treatment or prevention of diabetes, and more particularly type-II diabetes, diabetes-related complications, such as arthritis of the lower extremities, cardiac infarction, renal insufficiency, neuropathy or blindness, hyperglycemia, hyperinsulinemia, obesity, hypertriglyceridemia, X syndrome and arteriosclerosis, as well as for its use as an anticancer, anti-infective, anti-viral, anti-thrombotic or anti-inflammatory drug, or for lightening, bleaching, depigmenting the skin, removing blemishes from the skin, particularly age spots and freckles, or preventing pigmentation of the skin.Type: ApplicationFiled: May 29, 2012Publication date: April 17, 2014Applicant: TF-CHEMInventors: Geraldine Deliencourt-Godefroy, Lenaig Lopes
-
Publication number: 20130171180Abstract: The present invention relates to compounds of formula (I): or a pharmaceutically acceptable salt thereof, a tautomer, a stereoisomer or a mixture of stereoisomers in any proportion, in particular a mixture of enantiomers, and particularly a racemate mixture, as well as to their process of preparation, their use in the peptide synthesis, said peptide and the use of said peptide.Type: ApplicationFiled: December 22, 2011Publication date: July 4, 2013Applicant: TFCHEMInventors: Geraldine Deliencourt-Godefroy, Hyacinthe Fillon, Thibaut Martin